Werbung
Werbung

CLB

CLB logo

Core Laboratories Inc.

18.96
USD
Gesponsert
+0.08
+0.41%
09. Jan., 15:59 UTC -5
Geschlossen
exchange

Nach-Markt

19.00

+0.04
+0.23%

CLB Ergebnisberichte

Positives Überraschungsverhältnis

CLB übertreffen die 20 der letzten 39Schätzungen.

51%

Nächster Bericht

Datum des nächsten Berichts
29. Jan. 2026
Estimate for Q4 25 (Revenue/ EPS)
$132.41M
/
$0.19
Implizierte Änderung von Q3 25 (Revenue/ EPS)
-1.57%
/
-13.64%
Implizierte Änderung von Q4 24 (Revenue/ EPS)
+2.46%
/
-13.64%

Core Laboratories Inc. earnings per share and revenue

On 22. Okt. 2025, CLB reported earnings of 0.22 USD per share (EPS) for Q3 25, beating the estimate of 0.19 USD, resulting in a 12.88% surprise. Revenue reached 134.52 million, compared to an expected 132.61 million, with a 1.44% difference. The market reacted with a +28.82% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 4 analysts forecast an EPS of 0.19 USD, with revenue projected to reach 132.41 million USD, implying an decrease of -13.64% EPS, and decrease of -1.57% in Revenue from the last quarter.
FAQ
For Q3 2025, Core Laboratories Inc. reported EPS of $0.22, beating estimates by 12.88%, and revenue of $134.52M, 1.44% above expectations.
The stock price moved up 28.82%, changed from $12.77 before the earnings release to $16.45 the day after.
The next earning report is scheduled for 29. Jan. 2026.
Based on 4 analysts, Core Laboratories Inc. is expected to report EPS of $0.19 and revenue of $132.41M for Q4 2025.
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung